SNCA and Parkinson disease: Likewise, decreased expression of miR-133b and miR-153 have also been associated with the pathogenesis of PD; the former regulates RhoA, an axonal growth inhibitor, with the consequent induction of axonal growth, and also inhibits the expression of α-synuclein [151].